- Home
- MLYS vs TIPT Comparison
MLYS vs TIPT Comparison
Compare MLYS & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- TIPT
- Stock Information
- Founded
- MLYS 2019
- TIPT 2007
- Country
- MLYS United States
- TIPT United States
- Employees
- MLYS N/A
- TIPT N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- TIPT Property-Casualty Insurers
- Sector
- MLYS Health Care
- TIPT Finance
- Exchange
- MLYS Nasdaq
- TIPT Nasdaq
- Market Cap
- MLYS 890.6M
- TIPT 856.4M
- IPO Year
- MLYS 2023
- TIPT 2007
- Fundamental
- Price
- MLYS $14.89
- TIPT $23.50
- Analyst Decision
- MLYS Strong Buy
- TIPT
- Analyst Count
- MLYS 4
- TIPT 0
- Target Price
- MLYS $27.00
- TIPT N/A
- AVG Volume (30 Days)
- MLYS 869.6K
- TIPT 136.4K
- Earning Date
- MLYS 08-12-2025
- TIPT 07-30-2025
- Dividend Yield
- MLYS N/A
- TIPT 1.03%
- EPS Growth
- MLYS N/A
- TIPT 74.19
- EPS
- MLYS N/A
- TIPT 1.29
- Revenue
- MLYS N/A
- TIPT $2,024,136,000.00
- Revenue This Year
- MLYS N/A
- TIPT N/A
- Revenue Next Year
- MLYS N/A
- TIPT N/A
- P/E Ratio
- MLYS N/A
- TIPT $18.05
- Revenue Growth
- MLYS N/A
- TIPT 6.10
- 52 Week Low
- MLYS $8.24
- TIPT $17.07
- 52 Week High
- MLYS $18.38
- TIPT $26.90
- Technical
- Relative Strength Index (RSI)
- MLYS 55.68
- TIPT 63.36
- Support Level
- MLYS $14.26
- TIPT $20.79
- Resistance Level
- MLYS $15.55
- TIPT $23.47
- Average True Range (ATR)
- MLYS 0.85
- TIPT 0.91
- MACD
- MLYS 0.18
- TIPT 0.23
- Stochastic Oscillator
- MLYS 77.53
- TIPT 89.29
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.